![Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8b9a870f-3e09-486c-9c8f-90b1ee588b98/mco2349-fig-0004-m.jpg)
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library
![Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e59852a5-6f4a-4fb6-aee4-f210799ec76a/mco2349-gra-0001-m.jpg?trick=1698045793586)
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets - Li - 2023 - MedComm - Wiley Online Library
![Biomedicines | Free Full-Text | Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets? Biomedicines | Free Full-Text | Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?](https://www.mdpi.com/biomedicines/biomedicines-09-00365/article_deploy/html/images/biomedicines-09-00365-g001.png)
Biomedicines | Free Full-Text | Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
![IJMS | Free Full-Text | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance IJMS | Free Full-Text | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance](https://www.mdpi.com/ijms/ijms-22-07249/article_deploy/html/images/ijms-22-07249-g001.png)
IJMS | Free Full-Text | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance
![Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) | Signal Transduction and Targeted Therapy Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01119-3/MediaObjects/41392_2022_1119_Fig1_HTML.png)